Introduction
Non-small-cell lung cancer (NSCLC) is a leading cause of mortality due to its highly metastatic nature. Improved insight into molecular mechanisms of metastatic NSCLC is urgently required, but few experimental systems accurately reflect the clinical situation of human lung cancer . Existing xenograft models rarely involve orthotopic implantation of cells or produce a high yield of systemic metastases. We previously reported on a 'two-step' human lung cancer orthotopic model in nude rats that consistently metastasizes to mediastinal lymph nodes, bone, kidney, brain and soft tissue (Howard et al., 1999) . In the first step, endobronchial implantation of NCI-H460 cells produces a primary tumor with mediastinal lymph node metastases, but rarely systemic metastases. In the second step, fragments of the primary tumor from step one are implanted endobronchially to yield a primary lung tumor, regional and widespread systemic metastases.
Here, we report the isolation and molecular characterization of a novel variant H460SM cell line. When H460SM cells are orthotopically implanted into nude rats, spontaneous metastases to various extrathoracic organs and mediastinal lymph nodes occur and the second, fragment implantation, step of the original model is not required. In comparison to the parental NCI-H460 cells, H460SM cells demonstrate clonal karyotypic and gene expression changes, which provide clues and candidate genes for the mechanisms underlying metastatic progression of NSCLC.
Results

H460SM cells with enhanced metastatic potential
The parental NCI-H460 and the H460SM cell lines produced primary lung tumors of similar size, and all animals developed mediastinal lymph node metastases. The parental NCI-H460 cells showed systemic metas-tases in 17% of the animals (two of 12), whereas H460SM cells produced systemic metastases in 100% of animals that were visible macroscopically or microscopically (Table 1 ). The metastatic pattern of the H460SM cells, implanted orthotopically, was reproducible up to 13 passages. Both cell lines demonstrated a typical polygonal epithelial cell appearance in vitro, but the H460SM cells appeared more stellate and reflectile (Figure 1 ). There was no difference in their growth rates on plastic culture dishes, but the H460SM cells demonstrated a sixfold enhanced capacity for invasion through Matrigel (Figure 1 ). The primary tumors demonstrated a large-cell carcinoma appearance composed of sheets of undifferentiated and large malignant epithelial cells (Figure 2a and b) . A variant of the H460 cell line called H460LNM35 with increased COX-2 expression was previously shown to metastasize to axillary lymph nodes in a murine model (Kozaki et al., 2000) . We therefore investigated for COX-2 expression in our model. In vitro, the parental line expressed barely detectable COX-2 protein, whereas the H460SM cells demonstrated high expression. (Figure 2e ). However, the primary tumors from both cell lines demonstrated similar COX-2 protein levels ( Figure 2e ) as detected by Western blotting and immunohistochemistry (Figure 2c and d). Thus, although COX-2 may still play an important role in metastasis, we could not explain the metastatic behavior of the H460SM cells based solely on a COX-2 mechanism.
Karyotype of H460SM cells
The parental NCI-H460 cells exhibited a clonal hypotriploid karyotype with 58 chromosomes that included monosomies, trisomies, nonreciprocal translocations and deletions (Figure 3a) . The karyotype of H460SM cells was also clonal and almost identical, except for the loss of an extra copy of chromosome 14 and acquisition of an inversion within chromosome 17q. The NCI-H460 cells showed two normal chromosome 14 and one copy of chromosome 14 in der(10;14), whereas the H460SM cells demonstrated loss of a single copy of chromosome 14 ( Figure 3b ).
Expression profiling
Genome-wide analysis using high-density oligonucleotide microarrays demonstrated 403 probe sets corre- Tables  1 and 2 ). Consistent with the SKY analysis that demonstrated the loss of one normal copy of chromosome 14 and inversion of 17q, there was a high frequency of downregulated genes and no upregulated genes on chromosome 14, while 17 genes located on chromosome 17q were differentially expressed. However, gene expression changes were not confined to these chromosomes. A high frequency of downregulation of genes on chromosomes 6, 12, 15 and 18 was also detected, and of upregulation of genes on chromosome 19 (Figure 3c ). In total, 23 genes demonstrated a fourfold or higher increase (n ¼ 10) or decrease (n ¼ 13) in expression. Their biological functions, as implicated using the Netaffyx Gene Ontology (GO) Mining Tool (http://www.affymetrix.com), are shown in Table 2 . Of these, 12 genes representative of those with twofold or greater expression changes were selected for validation by quantitative real-time RT-PCR ( Figure 4 ). There was a high degree of concordance between the gene expression changes detected by Affymetrix with those detected by real-time PCR, but there were apparent discrepancies in the magnitude of the changes.
In silico analysis
To investigate the clinical relevance of candidate metastatic genes detected by expression profiling of the H460SM tumors, we examined the expression profiles of 173 genes that were present in the cDNA microarray database of 18 primary pulmonary adenocarcinomas. The clustering algorithm split the samples into two groups with markedly different clinical outcomes ( Figure 5 ). Group C1 (12 patients) contained 10 cases with recurrence and two cases without recurrence. Group C2 (six patients) comprised five nonrecurrent cases and one recurrent case. The nine highest ranked genes responsible for this partition were identified using the t-statistics and are listed in Table 3 . Kaplan-Meier analysis of the two patient groups demonstrated different survival curves with borderline statistical significance (P ¼ 0.06).
Discussion
The parental NCI-H460 cell line gives rise to a primary lung tumor and mediastinal lymph node metastases when implanted orthotopically into the lungs of nude rats, but systemic metastases are rare. By selectively harvesting tumor cells from these mediastinal lymph nodes and subjecting them to several cycles of in vitro and in vivo orthotopic passage, we have established a clonal H460SM variant cell line that spontaneously produces widespread systemic metastases following orthotopic implantation. In contrast to the two-step NCI-H460 metastatic model that we reported previously (Howard et al., 1999) , the one-step metastatic model with the H460SM cell line provides a simpler system to characterize molecular mechanisms that lead to systemic metastases, in addition to mediastinal lymph node metastasis. Here, we show that differentially expressed genes from this model can be used for in silico discovery of novel candidate metastatic and prognostic genes from existing lung cancer microarray databases.
To our knowledge, the H460SM orthotopic model represents the first lung cancer rodent model derived from a human lung cancer cell line that closely mimics the spectrum of common metastatic sites observed in NSCLC patients. Previously, Kozaki et al. (2000) also used the NCI-H460 cell line as a basis to establish a lymphogenous metastasis model of NSCLC. In their model, the H460-LNM35 cell line was established following serial in vivo selection steps that included two rounds of implantation into the abdominal wall of nude mice and culturing of cells from the lung metastatic nodules. Cells were then passaged through the subcutaneous tissue and the LNM35 cell line was established from metastatic tumor cells in the axillary lymph node. When implanted subcutaneously, the LNM35 cell line gave rise to axillary lymph node metastases in 100% of injected animals. Following endobronchial (orthotopic) implantation of LNM35 cells into the lungs of nude mice, mediastinal lymph node metastases were also noted in 100% of the animals. In contrast to the H460SM model presented here, neither the subcutaneous nor orthotopic implantation of the LNM35 cell line resulted in systemic metastases. In another model using the PC9, PC14 and A549 lung adenocarcinoma cell lines (Gemma et al., 2001; Shindo-Okada et al., 2001 , putative highly 'metastatic' variant cell lines with enhanced lung colonizing potential were isolated by cycles of in vivo and in vitro passages following repeated tail vein injection and harvesting of the lung tumor nodules. Some of these variant cell lines have demonstrated increased invasive activity in the Matrigel invasion assay. Strictly speaking, however, this latter model does not truly recapitulate the clinical condition in lung cancer patients. Microarray studies comparing the H460-LNM35 and the parental NCI-H460 cell lines cultured in vitro revealed a distinct set of gene expression changes, many of which were mimicry of inflammatory cells (Kozaki et al., 2001 ). In addition, cDNA microarray studies comparing the expression profiles of f9 and f14 metastatic variants of the PC9 cells to the parental nonmetastatic cells also identified 15 differentially expressed genes (Gemma et al., 2001) , which were different from those identified in the H460LNM35 model. There is only slight overlap between these sets of genes and the differentially expressed genes identified in our present study. The few overlaps that were associated with the metastatic phenotype in both our H460SM model and in the H460-LNM35 model (Kozaki et al., 2001 ) include decreased expression of cadherin 11, CD24, solute carrier family 16 and galactosylceramidase. The disparities in gene expression among these models may be attributed to the different types of microarray used, and may also be due to the effects of in vitro growth, compared to in vivo growth, where tumor-stromal cell interactions and the tissue microenvironment influences gene expression. We have noted inconsistencies between gene expression in cells grown on tissue culture plastic or Matrigel compared to that in animal models (data not shown).
In total, we identified 360 genes that were differentially expressed at least twofold in the metastatic H460SM lung tumors compared to the parent NCI-H460 lung tumors. Interestingly, all genes located on chromosome 14 were downregulated, while genes on 17q were up-or downregulated. These would be consistent with the cytogenetic findings of loss of one normal copy of chromosome 14 and inversion of 17q in the H460SM cells. Notably, two of the overlap genes between the H460SM and H460-LNM35 models are located on these chromosomes. The monocarboxylic acid transporter gene solute carrier family 16 is located on chromosome 17q25.2. The lysosomal enzyme galactosylceramidase is located on chromosome 14q31. Transcriptional repression of galactosylceramidase has been demonstrated in squamous cell carcinoma of the larynx (Gorogh et al., 1999) , but a role for solute carrier family 16 in cancer has not been reported. Other chromosome 14 genes, galectin 3 (14q21-22) and CRIP 2 (14q32.3) were also demonstrated to be downregulated in the H460-LNM35 Kozaki et al. (2001) . Expression changes were also noted in genes located on other chromosomes, some of these could possibly be under the regulatory control of genes on chromosomes 14 and 17q. Several candidate genes with a role in adhesion were identified in this model and validated by real-time RT-PCR. Cadherin 11 has been noted to suppress metastasis in a rodent model of osteosarcoma (Kashima et al., 2003) . Bullous pemphigoid antigen 1 is a specific constituent of junctional anchoring complexes termed hemidesmosomes and desmoplakin organizes the cytoskeleton in adhesion complexes called desmosomes (Fontao et al., 2003) . The integrin beta 4 gene is located on chromosome 17q and its product is a signaling receptor that mediates cell-matrix adhesion and promotes cancer cell invasion, possibly through the activation of phosphoinositide-3 kinase (Shaw et al., 1997) . The ROBO1/DUTT1 gene, homologous to the Drosophila roundabout gene, is believed to disrupt cell adhesion by phosphorylating beta-catenin, which in turn promotes uncoupling of N-cadherin from the cytoskeleton (Rhee et al., 2002) .
To investigate the potential clinical significance of this model, we identified 173 genes for which the expression data in 18 primary lung adenocarcinoma were also present in our previously published NSCLC cDNA microarray data set . Remarkably, using this subset of genes and the Binary TreeStructured Vector Quantization (BTSVQ) unsupervised clustering program (Sultan et al., 2002) , these patients were clustered into two groups with markedly different clinical outcomes ( Figure 5 ). The analysis isolated nine genes that ranked highest for their importance in the partitioning of these cases. Several of these have been implicated as playing an important role in oncogenesis. Raf-1 is a homologue of the v-raf oncogene and is a critical signaling transducer of the ras oncogene (Mercer and Pritchard, 2003) . G-protein-coupled receptor (GPR)56 is a secretin-like human GPR gene (Liu et al., 1999) . Although the role of GPR56 in cancer and Figure 5 Prediction of metastatic recurrence in primary NSCLC using 173 genes identified from the H460SM model. The BTSVQ algorithm was applied to cluster 18 lung adenocarcinoma cases according to the expression profile of 173 genes that were previously obtained by cDNA microarray experiments . The green and red colors in the binary tree designate patients who survived without recurrence or who relapsed with metastases after surgical resection of the primary tumor. The gene expression changes of the cases represented by SOM demonstrated the contrast between the expression profiles of cases with markedly different clinical outcome. The Kaplan-Meier curves of patients in the two first level clusters demonstrated a borderline (P ¼ 0.06) difference in their overall survival (Marinissen and Gutkind, 2001; Sattler and Salgia, 2003) . Lastly, EP300 is a histone acetyltransferase that plays an important role in regulating chromatin remodeling and gene transcription. Mutational inactivations of EP300 have been reported in various types of epithelial cancer (Gayther et al., 2000) . Although none of the nine highest ranked genes have previously been identified as potential prognostic marker genes in NSCLC microarray studies (Bhattacharjee et al., 2001; Garber et al., 2001; Beer et al., 2002; Miura et al., 2002; Wigle et al., 2002; Nakamura et al., 2003) , it is worth noting that very little overlap exists among the gene lists reported in these studies. We previously reported recurrence risk prediction of NSCLC using a set of 2899 genes, but none of the most significant genes for disease-free survival in the Cox's proportional hazards model were present in the list of genes obtained for the H460SM model. The former genes were applicable to 39 cases of NSCLC with mixed histological subtypes, so different sets of prognostic genes may be applicable to different types of lung cancer. Inquiry of the other published microarray data sets using the 360 genes we identified here could reveal additional candidate marker genes for subsets of NSCLC. Among the 360 genes, Cadherin 11 and A kinase (PRKA) anchor protein (gravin) 12 were included in the prognostic gene sets discovered by Nakamura et al. (2003) and Beer et al. (2002) .
It is believed that additional microarray studies using larger numbers of more homogeneous groups of tumors (e.g. same stage), and analysis of microarray data using multiple computational and statistical algorithms, will be necessary to extract the best candidate prognostic marker genes for NSCLC (Wigle et al., 2004) . In an elegant study using in vivo selection in mice for highly metastatic human breast cancer cells, Kang et al. (2003) identified an expression signature of 102 genes associated with osteolytic bone metastases. Notably, none of these genes belong to the previously identified 'poorprognosis' breast cancer signature expression profile (van t'Veer et al., 2002) . Our study also demonstrates that animal models of metastatic lung cancer may be used to screen microarray expression databases and select novel candidate prognostic signature genes for further validation.
Materials and methods
Orthotopic model and isolation of the H460SM cell line
Male nude (CR:NIH-RNU) rats (Charles River Inc., Frederick Cancer Research Facility, Frederick, MD, USA) aged 4 weeks were acclimatized for 1-2 weeks before entering study protocols, housed in sterilized cages, fed autoclaved food and water ad libitum, and assessed daily for general health. Manipulations were made in a sterile laminar flow hood according to procedures approved by the Institutional Animal Care Committee at the Ontario Cancer Institute. NCI-H460 cell line at passage 136 (ATCC HTB 177) from the American Type Culture Collection (Rockville, MD, USA) was derived from a large-cell lung carcinoma (Carney et al., 1985) . Cells were cultured at 371C in RPMI 1640 media containing 5% fetal bovine serum in a 5% CO 2 atmosphere and passaged at 80% confluence. In vivo propagation and selection of the new metastatic variant H460SM cell line started with the orthotopic lung cancer model and endobronchial tumor cell implantation technique as previously described in detail (Howard et al., 1999) . Tumor cells from the mediastinal lymph nodes were harvested under aseptic conditions and mechanically dispersed for primary culture. Following expansion in vitro, cells were reimplanted endobronchially into the nude rats. When lung tumors were formed, the rats were killed and tumor cells in the mediastinal lymph nodes were again harvested for culturing. After four such cycles of in vivo-in vitro selection and culture, the implanted tumor cells were found to generate extensive systemic metastases and the variant cells were designated the H460SM line.
Phenotypic characterization of H460SM
To assess growth in vitro, cells were dissociated from monolayer cultures by brief trypsinization, washed in cold Hanks' balanced salt solution and 1.0. Â 10 5 cells seeded onto replicate wells of six-well tissue culture dishes. At daily intervals, cells from triplicate wells were trypsinized, counted with a coulter cell counter (Coulter Electronics, Luton, UK) and cell numbers averaged for each time interval. Tumor cell invasion was assessed in vitro by the reconstitute basement membrane (Matrigel) invasion assay (Saiga et al., 1987) . Briefly, 5 Â 10 4 cells in 100 ml of medium containing 0.2% BSA were added to Matrigel (Collaborative Research, Bedford, MA, USA) coated 8 mm filters placed in 24-well plates. Rat fibronectin (5 mg/ml; Gibco BRL) was used as a chemoattractant in the lower chamber. Following 48 h incubation at 371C, filters were fixed in 0.1% glutaraldehyde, stained with 0.2% crystal violet and the cells on the upper surface of the filter were removed with a cotton swab. In all, 20 random fields per filter were counted using a Nikon Inverted microscope ( Â 100). Experiments were performed in duplicate and control filters were coated with 7.5 mg/ml human placental type IV collagen (Sigma) to assess for changes in cell migration.
To assess growth in vivo 1.5 Â 10 6 cells/70 ml H460SM cells were orthotopically implanted via the endobronchial or transthoracic route as described previously (Howard et al., 1999) . Animals succumbed to disease or were killed when death was imminent due to tumor progression. Metastatic occurrences were defined as any visible tumor deposit other than the primary tumor assessed macroscopically and microscopically. The internal organs, including the lung, kidney, brain, chest wall and bone, as well as mediastinal lymph nodes, were removed from the euthanized animals, weighed, fixed in 10% buffered formalin, serially sectioned and processed for histological examination. Portions of primary tumors were also snap-frozen and stored in liquid nitrogen for future molecular and proteomics studies.
COX-2 expression
For Western blot analysis of COX-2 expression, cells and tumor tissue were homogenized in lysis buffer (1% Triton X-100, 10% glycerol, 50 mM HEPES, 150 mM NaCl, 1.5. mM MgCl2, 10 mM sodium pyrophsophate100 mM NaF, 10 mM 1 mM EDTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 100 mg/ ml phenylmethylsulfonyl fluoride and 1 mM sodium orthovanadate) and the lysates were cleared by centrifugation. Protein Expression profiling of a metastatic lung cancer model J Liu et al samples (100 mg) were fractionated on 8% SDS-polyacrylamide gel and transferred onto PVDF membranes. The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween-20. Mouse monoclonal antibody to COX-2 (Cayman Chemical Co., Ann Arbor, MI, USA) was used at 1 : 1000 dilution. Following incubation with the appropriate secondary antibodies, immunoreactive protein bands were detected by enhanced chemiluminescence (Roche). The membranes were then stained with amido black to demonstrate comparable protein loading. Standard immunohistochemistry for COX-2 was performed on formalin-fixed and paraffin-embedded 4-mm tumor tissue sections. After microwave antigen retrieval in 10 mM citrate buffer, pH 6.0 in a pressure cooker, slides were blocked for endogenous biotin with Vector's biotin blocking kit, then normal serum, then covered in primary antibody (1 : 4000) for 1 h at room temperature. Following washing in phosphatebuffered saline, secondary antibody incubation was carried out with the multispecies link Ultra-streptavidin detection system (Signet Pathology System, Dedham, MA, USA), then with streptavidin-horse raddish peroxidase for 20 min each. Immunoreactivity was revealed by incubation in Nova Red substrate (Vector Laboratories, Burlingame, CA, USA) for 5 min. Slides were counterstained in Mayer's hematoxylin and mounted with Permount.
Spectral karyotyping (SKY)
Cells were treated with colcemid (0.05. mg/ml) for 4 h, hypotonized with 0.075 M KCl for 20 min at 371C, then fixed with methanol/acetic acid 3 : 1. Slides with metaphase spreads were prepared for hybridization with human SKY probe (Applied Spectral Imaging (ASI), Carslbad, CA, USA) according to the manufacturer's instructions. Metaphase images were acquired by Spectral Imaging software (ASI) and analysed by SkyView software (ASI). For all cell lines, 10 metaphases were examined. The description of chromosomal changes was performed according to ISCN 1995 guidelines.
Expression profiling
Total cellular RNA was isolated from primary orthotopic tumors using the guanidium isothiocyanate-phenol-chloroform method as described previously (Tsao et al., 1998) . RNA was further purified using an RNeasy kit (Qiagen Inc., Mississauga, Ontario, Canada) and the quality of RNA preparation confirmed using an Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). The gene expression profiles of the primary orthotopic tumors were examined using the U133A human oligonucleotide GeneChip (Affymetrix Inc., Santa Clara, CA, USA). Total RNA (20 mg) pooled from three separate tumor tissue samples generated by the same cell line in different rats was labeled and hybridized onto arrays at The Centre of Applied Genomics (Hospital for Sick Children, Toronto, Canada, http://tcag.bioinfo.sickkids.on.ca/index.php?pagename ¼ microarray.php) according to the standard Affymetrix protocol (http://www.affymetrix.com/ support/technical/manual/expression_manual.affx). Raw array image data were analysed using Affymetrix MAS 5.0 software and arrays were scaled to a mean intensity of 150. The biological functions of differentially expressed genes were explored using the Netaffyx Gene Ontology (GO) Mining Tool (http://www.affymetrix.com), the Locus link and Medline databases.
Selected genes identified by oligonucleotide microarray were measured using real-time RT-PCR. Two independent assays were performed in duplicate on cDNA from three separate orthotopic tumors of each cell line. DNAse-(Ambion, Austin, TX, USA) treated total cellular RNA (5 mg) was reversed transcribed using Taqman Reverse Transcription reagents and Random Hexamer primer (Perkin-Elmer Applied Biosystems, Foster City, CA, USA). A 10 ng equivalent of cDNA was used for each quantitative PCR assay performed with the ABI PRISM 7700 Sequence Detection System, as previously described in detail (Wang et al., 2002) . The sequences of gene transcripts that corresponded to the affymetrix probe set were obtained from www.ensembl.org and primer sets were designed using the Primer Express software (Perkin-Elmer Applied Biosystems), and the primer sequences are available at http://individual.utoronto.ca/mrj/h460sm (Supplementary Table 3). The C T represented the relative abundance of a transcript and the 18s ribosomal RNA transcript level was used to monitor the sample to sample variation of RNA/ cDNA quantity using the delta C T method (Wang et al., 2002) .
In silico validation
Out of 360 genes that changed by twofold or greater in the orthotopic H460SM tumors, we found a subset of 173 genes that were also represented by cDNA probes in the OCI 19.2K. arrays (http://www.microarrays.ca). The microarray data of lung cancer samples (http://www.cs.utoronto.ca/~juris/publicationsData.html) that we previously obtained by profiling on the OCI 19.2K arrays were used for an unsupervised clustering analysis based on the subset of 173 overlapping genes. Analyses were performed both on all 39 NSCLC cases as well as on the subset of 18 adenocarcinoma cases (Supplementary Table 4 ). The Binary Tree-Structured Vector Quantization (BTSVQ) software that combines selforganizing maps (SOM) and partitive k-means clustering was used (Sultan et al., 2002) . The analysis starts by taking the expression values of 173 genes for each specimen. Then, the standard k-means algorithm, where k is kept constant at 2, is used to partition the data. By iteratively applying the algorithm and using evaluation of variance as a stopping criterion, a binary tree is generated ( Figure 5 ). The SOM algorithm is then used to cluster the gene space and provide visualization of the gene expression in each sample using component planes ( Figure 5 ). This type of analysis is best suited to clinically heterogeneous samples where gene expression patterns of interest may not occur at the first dichotomous split (partition) of the binary tree, since it strongly depends on the samples considered at each level of the tree. Sample clusters of clinical interest may split at different levels comprising a subset of the total sample population. For each level of the binary tree the genes are ranked both with respect to quantization error, which is the likelihood of the gene being differentially expressed across all the samples in the same cluster, and t-statistics. This provides an accurate method of excluding genes with variable expression across samples, as well as genes with low significance, and thus enables selection of the most differentiating genes between clusters. The survival curves of the patients in first level split clusters were performed based on the Kaplan-Meier estimates. Overall survival was evaluated from the date of surgery to the date of last follow-up or until death occurred. No patient died before experiencing a relapse.
